Literature DB >> 19724898

Effect of polymorphisms of IL-17A, -17F and MIF genes on CpG island hyper-methylation (CIHM) in the human gastric mucosa.

Tomomitsu Tahara1, Tomoyuki Shibata, Masakatsu Nakamura, Hiromi Yamashita, Daisuke Yoshioka, Masaaki Okubo, Joh Yonemura, Yoshiteru Maeda, Naoko Maruyama, Toshiaki Kamano, Yoshio Kamiya, Hiroshi Fujita, Yoshihito Nakagawa, Mitsuo Nagasaka, Masami Iwata, Ichiro Hirata, Tomiyasu Arisawa.   

Abstract

CpG island hyper-methylation (CIHM) is one of the major events in the gastric carcinogenesis and also occurs in non-neoplastic gastric mucosa. IL-17A, -17F and MIF have a crucial role in the gastric inflammation and carcinogenesis. The CIHM status in the non-cancerous gastric mucosa, in relation to IL-17A (-197G>A, rs2275913), -17F (7488T>C, rs763780) and MIF (-173G>C and -794 tetranucleotide repeats) polymorphisms was investigated. Gastric mucosa samples were obtained from 121 cancer free subjects. CIHM of p14, p16, DAP-kinase and CDH1 genes were determined by methylation-specific polymerase chain reaction (MSP). CIHM high was defined as three or all CpG islands methylated. We employed the PCR-SSCP (multiplex PCR for IL-17A and -17F) method to detect the gene polymorphisms. No association were found between CIHM status and L-17A (-197G>A), IL-17F (7488T>C) and MIF (-173G>C) polymorphisms. MIF 5-CATT repeat carrier (5/5+5/6+5/7) held a significantly higher risk of CIHM of DAP-kinase (OR=2.33, 95% CI=1.07-5.09, p=0.03) and CIHM high (OR=3.63, 95% CI=1.31-10.08, p=0.01). Weak association was also found between the same genotype and increased risk of CIHM of p16 (OR=2.45, 95% CI=0.90-6.68, p=0.08) and CDH1 (OR=2.23, 95% CI=0.94-5.32, p=0.07). 6-CATT repeat carrier (5/6+6/6+6/7) was significantly associated with reduced risk of CIHM of p16 (OR=0.31, 95% CI=0.11-0.90, p=0.03), CDH1 (OR=0.40, 95% CI=0.17-0.98, p=0.045), DAP-kinase (OR=0.37, 95% CI=0.17-0.83, p=0.02) and CIHM high (OR=0.25, 95% CI=0.09-0.74, p=0.01). -7-CATT repeat carrier (6/7+7/7) was weakly associated with reduced risk of CIHM of p16 (OR=0.34, 95% CI=0.10-1.13, p=0.08), DAP-kinase (OR=0.43, 95% CI=0.17-1.06, p=0.07) and CIHM high (OR=0.38, 95%CI=0.12-1.20, p=0.098). The present results provided the first evidence that the genetic polymorphisms MIF polymorphism is associated with CIHM status in the human gastric mucosa. Genetic polymorphisms of MIF-794-CATT repeat may be involved in methylation related carcinogenesis in the stomach.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19724898     DOI: 10.3892/ijmm_00000266

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  6 in total

1.  Association Between Genetic Polymorphism of the MIF Gene and Colorectal Cancer in Taiwan.

Authors:  Latha Ramireddy; William Tzu-Liang Chen; Ching-Tien Peng; Rouh-Mei Hu; Tao-Wei Ke; Hua-Che Chiang; Sheng-Chi Chang; Fuu-Jen Tsai; Wan-Yu Lo
Journal:  J Clin Lab Anal       Date:  2014-05-19       Impact factor: 2.352

2.  Methylation pattern of THBS1, GATA-4, and HIC1 in pediatric and adult patients infected with Helicobacter pylori.

Authors:  Marisa Claudia Alvarez; Marcelo Sady Placido Ladeira; Isabel Cristina Affonso Scaletsky; José Pedrazzoli; Marcelo Lima Ribeiro
Journal:  Dig Dis Sci       Date:  2013-06-14       Impact factor: 3.199

3.  Effect of Helicobacter pylori Infection on GATA-5 and TFF1 Regulation, Comparison Between Pediatric and Adult Patients.

Authors:  Marisa Claudia Alvarez; Julien Fernandes; Valérie Michel; Eliette Touati; Marcelo Lima Ribeiro
Journal:  Dig Dis Sci       Date:  2018-08-06       Impact factor: 3.199

4.  Significant association between interleukin-17A polymorphism and colorectal cancer.

Authors:  Inés Omrane; Raja Marrakchi; Olfa Baroudi; Amel Mezlini; Hager Ayari; Imen Medimegh; Nejla Stambouli; Nadia Kourda; Hassen Bouzaienne; Nancy Uhrhammer; Karim Bougatef; Yves-Jean Jean Bignon; Amel Benammar-Elgaaied
Journal:  Tumour Biol       Date:  2014-04-04

5.  Influence of IL17A polymorphisms on the aberrant methylation of DAPK and CDH1 in non-cancerous gastric mucosa.

Authors:  Tomiyasu Arisawa; Tomomitsu Tahara; Mikihiro Tsutsumi; Tomoyuki Shibata
Journal:  BMC Med Genet       Date:  2012-07-24       Impact factor: 2.103

6.  Involvement of IL17A, IL17F and IL23R Polymorphisms in Colorectal Cancer Therapy.

Authors:  Inés Omrane; Imen Medimegh; Olfa Baroudi; Hager Ayari; Walid Bedhiafi; Nejla Stambouli; Marwa Ferchichi; Nadia Kourda; Yves-Jean Bignon; Nancy Uhrhammer; Amel Mezlini; Karim Bougatef; Amel Benammar-Elgaaied
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.